Asia-Pacific: Antisera Market 2023

Antisera Market Size in Asia-Pacific

The Asia-Pacific antisera market expanded sharply to $X in 2022, growing by X% against the previous year. In general, consumption enjoyed a prominent expansion. The level of consumption peaked in 2022 and is likely to continue growth in the immediate term.

Antisera Production in Asia-Pacific

In value terms, antisera production reached $X in 2022 estimated in export price. In general, production, however, enjoyed a buoyant increase. The most prominent rate of growth was recorded in 2020 with an increase of X%. As a result, production attained the peak level of $X. From 2021 to 2022, production growth remained at a somewhat lower figure.

Antisera Exports

Exports in Asia-Pacific

After three years of growth, overseas shipments of antisera and other blood fractions decreased by X% to X tons in 2022. Overall, exports, however, enjoyed a significant increase. The growth pace was the most rapid in 2021 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons, and then reduced sharply in the following year.

In value terms, antisera exports reduced rapidly to $X in 2022. In general, exports, however, showed significant growth. The most prominent rate of growth was recorded in 2020 when exports increased by X%. The level of export peaked at $X in 2021, and then dropped significantly in the following year.

Exports by Country

China was the key exporter of antisera and other blood fractions in Asia-Pacific, with the volume of exports resulting at X tons, which was approx. X% of total exports in 2022. Singapore (X tons) held a X% share (based on physical terms) of total exports, which put it in second place, followed by South Korea (X%). New Zealand (X tons) and India (X tons) held a minor share of total exports.

From 2012 to 2022, average annual rates of growth with regard to antisera exports from China stood at X%. At the same time, South Korea (X%), Singapore (X%), India (X%) and New Zealand (X%) displayed positive paces of growth. Moreover, South Korea emerged as the fastest-growing exporter exported in Asia-Pacific, with a CAGR of X% from 2012-2022. From 2012 to 2022, the share of South Korea, China and Singapore increased by X, X and X percentage points, respectively.

In value terms, the largest antisera supplying countries in Asia-Pacific were South Korea ($X), Singapore ($X) and China ($X), with a combined X% share of total exports.

South Korea, with a CAGR of X%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Asia-Pacific stood at $X per ton in 2022, surging by X% against the previous year. In general, the export price saw a noticeable expansion. Over the period under review, the export prices hit record highs at $X per ton in 2019; however, from 2020 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was South Korea ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (X%), while the other leaders experienced more modest paces of growth.

Antisera Imports

Imports in Asia-Pacific

In 2022, after ten years of growth, there was significant decline in overseas purchases of antisera and other blood fractions, when their volume decreased by X% to X tons. Overall, imports, however, enjoyed a resilient increase. The most prominent rate of growth was recorded in 2021 when imports increased by X%. As a result, imports attained the peak of X tons, and then fell in the following year.

In value terms, antisera imports stood at $X in 2022. Over the period under review, imports, however, continue to indicate a resilient increase. The most prominent rate of growth was recorded in 2019 when imports increased by X%. The level of import peaked in 2022 and is expected to retain growth in the immediate term.

Imports by Country

In 2022, China (X tons), distantly followed by Australia (X tons), Taiwan (Chinese) (X tons), Singapore (X tons), Japan (X tons), the Philippines (X tons) and South Korea (X tons) were the major importers of antisera and other blood fractions, together constituting X% of total imports. Malaysia (X tons) took a relatively small share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by the Philippines (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Japan ($X), China ($X) and Australia ($X) were the countries with the highest levels of imports in 2022, with a combined X% share of total imports. South Korea, Taiwan (Chinese), Singapore, the Philippines and Malaysia lagged somewhat behind, together accounting for a further X%.

Among the main importing countries, the Philippines, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Asia-Pacific amounted to $X per ton, rising by X% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of X%. The growth pace was the most rapid in 2019 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2020 to 2022, the import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Japan ($X,598 per ton), while the Philippines ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by South Korea (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :